2021 Hard-to-Treat Award Winners
The Hard-To-Tread Award is a grant intended to support projects that enable the prevention, early detection and effective treatment of pediatri...
Exploring safe, cost-effective alternatives to donor-supplied blood
Cancer and the therapies used to treat it can alter the delicate blend of a child’s blood proteins. As a result, children with cancer often...
Catching infant neuroblastoma earlier for better outcomes
Even before a baby is born, neuroblastoma can start to quietly creep through their nerve cells, growing into a tumor that might go undetected f...
Helping the immune system fight brain cancer
Even as a college student volunteering in the cancer ward of his local children’s hospital, Robert Galvin, MD, knew he wanted to become a ped...
Our top 5 research wins of 2021
It’s up to you to make a difference for kids fighting cancer - and in 2021, you delivered. Because of you we funded 40 new research...
Using artificial intelligence to optimize childhood brain tumor treatment
Brain tumors recently rose to be the most common cause of cancer-related death in kids. Those that survive can develop serious negative...
Improving communication and trust between cancer families and care teams
Communication breakdowns between patients, parents, doctors, nurses and other medical professionals could result in unnecessary stress and...
Dream Further Campaign hits $2 million for cancer survivorship research and care
When childhood cancer survivor Ted Sibley finished his cancer treatment as a teenager, he received a t-shirt that said, “Finish Line.” He was...
Does body composition impact the severity of chemo side-effects in children?
The research questions started to percolate for pediatric oncologist Aman Wadhwa, MD, MSPH, as he made his rounds of the pediatric oncology uni...
CCRF-funded researcher is outsmarting the defenses of AML cancer cells
Shannon Conneely, MD, a pediatric hematologist-oncologist at Texas Children’s Hospital and researcher at Baylor College of Medicine, envision...
Discovering the cell origin of Ewing sarcoma
For decades, the question of Ewing sarcoma’s genetic beginnings has stumped scientists, leaving potential therapeutic targets...
Exploring unconventional paths to new treatments for childhood rhabdoid tumors
Capucine Van Rechem was still a teenager when cancer stole away both her parents. First her mother died of breast cancer, and then her father p...
CCRF-funded researcher to open immunotherapy clinical trial for hepatoblastoma
O’Neill, a recipient of the Emerging Scientist Award from Children’s Cancer Research Fund (CCRF), is studying a new therapy to treat children...
8 new scientists will kickstart their projects thanks to CCRF
Many great ideas go unexplored in the childhood cancer world due to a lack of funding. Thanks to donors like you, eight new projects are...
Setting the Stage for First-Ever Targeted Treatment of an Extremely Rare Sarcoma
Dr. Okimoto studies a deadly subset of sarcoma, cancer that develops in the bone or tissue, called CIC-DUX4 sarcoma. He estimates only about...
Sneaking past medulloblastoma’s micro-defenses
CCRF Emerging Scientist Award winner Giedre Krenciute is developing a Trojan horse of sorts to sneak past medulloblastoma’s armed defenses...
CCRF-funded researcher uses microscopic protein pathways to beat graft-versus-host disease
Kids like Alex often need blood or marrow transplants (BMTs) as part of their treatment plans. Typically, these transplants use immune cells...
Researchers investigate existing drugs to treat AML more safely
The last time Children’s Cancer Research Fund donors heard about Ani Deshpande, Ph.D. assistant professor at Sanford Burnham Prebys Medical...